• shareshare
  • link
  • cite
  • add
auto_awesome_motion View all 2 versions
Publication . Article . 2005

Shared reactivity of Vδ2neg γδ T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells

Halary, Franck; Pitard, Vincent; Dlubek, Dorota; Krzysiek, Roman; de la Salle, Henri; Merville, Pierre; Dromer, Claire; +3 Authors
Open Access   English  
Published: 16 May 2005 Journal: The Journal of Experimental Medicine, volume 201, issue 10, pages 1,567-1,578 (issn: 0022-1007, eissn: 1540-9538, Copyright policy )
Publisher: The Rockefeller University Press
Long-lasting expansion of Vδ2neg γδ T cells is a hallmark of cytomegalovirus (CMV) infection in kidney transplant recipients. The ligands of these cells and their role remain elusive. To better understand their immune function, we generated γδ T cell clones from several transplanted patients. Numerous patient Vδ1+, Vδ3+, and Vδ5+ γδ T cell clones expressing diverse Vγ chains, but not control Vγ9Vδ2+ T clones, displayed strong reactivity against CMV-infected cells, as shown by their production of tumor necrosis factor-α. Vδ2neg γδ T lymphocytes could also kill CMV-infected targets and limit CMV propagation in vitro. Their anti-CMV reactivity was specific for this virus among herpesviridae and required T cell receptor engagement, but did not involve major histocompatibility complex class I molecules or NKG2D. Vδ2neg γδ T lymphocytes expressed receptors essential for intestinal homing and were strongly activated by intestinal tumor, but not normal, epithelial cell lines. High frequencies of CMV- and tumor-specific Vδ2neg γδ T lymphocytes were found among patients' γδ T cells. In conclusion, Vδ2neg γδ T cells may play a role in protecting against CMV and tumors, probably through mucosal surveillance of cellular stress, and represent a population that is largely functionally distinct from Vγ9Vδ2+ T cells.
Subjects by Vocabulary

Microsoft Academic Graph classification: IL-2 receptor Interleukin 21 NKG2D Biology Immune system Major histocompatibility complex biology.protein T cell medicine.anatomical_structure medicine Cytotoxic T cell Streptamer Immunology


Article, Immunology, Immunology and Allergy

41 references, page 1 of 5

1 Constant, P., F. Davodeau, M.A. Peyrat, Y. Poquet, G. Puzo, M. Bonneville, and J.J. Fournié. 1994. Stimulation of human γδ T cells by nonpeptidic mycobacterial ligands. Science. 264:267–270. 8146660 [PubMed]

2 Tanaka, Y., C.T. Morita, E. Nieves, M.B. Brenner, and B.R. Bloom. 1995. Natural and synthetic non-peptide antigens recognized by human γδ T cells. Nature. 375:155–158. 7753173 [PubMed]

3 Kunzmann, V., E. Bauer, J. Feurle, F. Weissinger, H.P. Tony, and M. Wilhelm. 2000. Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood. 96:384–392. 10887096 [PubMed]

4 Bukowski, J.F., C.T. Morita, and M.B. Brenner. 1999. Human gamma delta T cells recognize alkylamines derived from microbes, edible plants, and tea: implications for innate immunity. Immunity. 11:57–65. 10435579 [PubMed]

5 Scotet, E., L.O. Martinez, E. Grant, R. Barbaras, P. Jeno, M. Guiraud, B. Monsarrat, X. Saulquin, S. Maillet, J.P. Esteve, et al. 2005. Tumor recognition following Vgamma9Vdelta2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I. Immunity. 22:71–80. 15664160 [OpenAIRE] [PubMed]

6 Groh, V., A. Steinle, S. Bauer, and T. Spies. 1998. Recognition of stress-induced MHC molecules by intestinal epithelial γδ T cells. Science. 279:1737–1740. 9497295 [PubMed]

7 Spada, F., E. Grant, P. Peters, M. Sugita, A. Melian, D. Leslie, H. Lee, E. van Donselaar, D. Hanson, A. Krensky, et al. 1999 Self-recognition of CD1 by γδ T cells: implications for innate immunity. J. Exp. Med. 191:937–948.

8 Carding, S.R., and P.J. Egan. 2002. Gammadelta T cells: functional plasticity and heterogeneity. Nat. Rev. Immunol. 2:336–345. 12033739 [PubMed]

9 Ferrarini, M., E. Ferrero, L. Dagna, A. Poggi, and M.R. Zocchi. 2002. Human gammadelta T cells: a nonredundant system in the immune-surveillance against cancer. Trends Immunol. 23:14–18. 11801449 [PubMed]

10 Wilhelm, M., V. Kunzmann, S. Eckstein, P. Reimer, F. Weissinger, T. Ruediger, and H.P. Tony. 2003. Gammadelta T cells for immune therapy of patients with lymphoid malignancies. Blood. 102:200–206. 12623838 [PubMed]